RAYMOND JAMES & ASSOCIATES - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$20,000
-25.9%
37,150
-8.6%
0.00%–
Q2 2020$27,000
+17.4%
40,6500.0%0.00%–
Q1 2020$23,000
-55.8%
40,650
+2.5%
0.00%–
Q4 2019$52,000–39,650–0.00%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders